English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

I read with great interest the recent article by Zhou et al. in a recent issue of your esteemed journal. The article is highly thought provoking. Interestingly, over the past few years, new data has emerged that reveals the emerging anticarcinogenic role of fluoxetine in systemic tumors besides breast carcinomas.

Emerging anticarcinogenic effects of fluoxetine besides its role in the treatment of breast carcinomas